Health Optimization Index
Oxiracetam
- Nick’s assessment
- Promising
- Research evidence
- C, mixed evidence
- Attention
- 12.7 / 100▲ Rising this week
BioHarmony score
Oxiracetam fits logical-work and mild stimulant experiments, with historical dosing around 800-2,400 mg/day and evidence led by Copani 1992 AMPA-receptor work. The practical problem is that healthy-user cognitive data and sourcing quality remain weak.
Read the full report Benefits, risks and practical guidance.
Read Nick’s assessment Why it earned this rating
Oxiracetam earns a middle-of-the-road score because the mechanism is real but the modern human evidence is thin and sourcing is now genuinely hard. It positively modulates AMPA glutamate receptors and has a mild, stimulant-like, logic-friendly character that some users value for focused cognitive work. What it does not have is a body of recent trials in healthy adults, so this is an informed personal experiment rather than a proven cognitive tool.
✅ Best for: Experienced nootropic users who want occasional support for focused, logical work, can verify a clean source, pair it with a choline source if they get headaches, and will judge it against a specific task instead of a vague sense of sharpness.
❌ Avoid if: You are pregnant or nursing, take medications that could interact, compete in tested sport, are sensitive to stimulants, or cannot confirm the purity of what you are buying. Skip it too if you have not yet dialed in sleep, training, and nutrition, since those move cognition far more reliably.
Share your experience
Your answers are optional and help other readers — they never change my score. How community input works.
One step left: confirm it’s you
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.
Make a 12-month prediction Will it rise or fall in the Index?
Choose a direction and your confidence. Correct predictions earn leaderboard points.
Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →